Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial
Authors:
Open Access
- 1 February 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 9 (2) , 174-181
Abstract
Heart failure (HF) is the leading cause of hospitalization in the US.1 Identification and classification of HF events is challenging due to clinical and phenotypic heterogeneity as well as the absence of definitive and scalable diagnostic testing. Yet the validity of HF randomized clinical trials, epidemiology, and outcomes research depends on accurate identification of HF hospitalization events. The time-intensive gold-standard for defining HF outcomes in most randomized clinical trials is for local sites to identify potential events and submit medical records to a central clinical events committee (CEC), a group of expert physicians who manually review the records and determine whether the case meets established criteria.2 For larger (primarily observational) studies for which CEC adjudication is impractical, International Classification of Disease (ICD) codes are commonly used to define HF hospitalizations.3,4 But ICD codes for HF are known to be imprecise: approximately 40% of hospitalizations with primary position ICD codes for HF do not meet established criteria on medical record review.5-8 Automated adjudication of HF hospitalizations from medical records at scale could streamline or reduce the need for physician CEC review and therefore may represent 1 step toward larger and less expensive clinical trials and more precise clinical outcome data for epidemiology research.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure TrialsCirculation: Heart Failure, 2020
- Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve ReplacementCirculation, 2020
- Color processing and management in GhostscriptColor and Imaging Conference, 2019
- Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic DiscoveryCirculation, 2019
- High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialAmerican Heart Journal, 2018
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsCirculation, 2018
- Electronic health records to facilitate clinical researchClinical Research in Cardiology, 2016
- The Prevention of Hospital Readmissions in Heart FailureProgress in Cardiovascular Diseases, 2016
- A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkJournal of Cardiovascular Translational Research, 2015
- Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of CareJournal of the American Heart Association, 2014